Restoration of periprosthetic bone loss by zoledronic acid in total hip arthroplasty with osteoporosis.
Not Applicable
- Conditions
- Osteoporotic patients treaed with Total hip arthroplasty
- Registration Number
- JPRN-UMIN000034736
- Lead Sponsor
- Osaka University Graduate School of Medicine, Orthopedic Medical Engineering
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
The criteria of osteoporosis were not fulfilled.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The changes of periprosthetic bone mineral density were compared and evaluated at two years.
- Secondary Outcome Measures
Name Time Method Bone mineral density, bone biomarker, Japanese orthopaedic asssciation hip scpre, WOMAC were compared between groups.